Camber Capital Management L.P. 13F annual report

Camber Capital Management L.P. is an investment fund managing more than $2.57 billion ran by Stephen Dubois. There are currently 34 companies in Mr. Dubois’s portfolio. The largest investments include Zimmer Biomet Inc and Baxter International, together worth $393 million.

Limited to 30 biggest holdings

$2.57 billion Assets Under Management (AUM)

As of 7th August 2024, Camber Capital Management L.P.’s top holding is 1,925,000 shares of Zimmer Biomet Inc currently worth over $209 million and making up 8.1% of the portfolio value. Relative to the number of outstanding shares of Zimmer Biomet Inc, Camber Capital Management L.P. owns more than approximately 0.1% of the company. In addition, the fund holds 5,500,000 shares of Baxter International worth $184 million, whose value fell 12.9% in the past six months. The third-largest holding is Medtronic Plc worth $177 million and the next is Universal Hlth Svcs Inc worth $176 million, with 950,000 shares owned.

Currently, Camber Capital Management L.P.'s portfolio is worth at least $2.57 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Camber Capital Management L.P.

The Camber Capital Management L.P. office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Stephen Dubois serves as the Managing Member at Camber Capital Management L.P..

Recent trades

In the most recent 13F filing, Camber Capital Management L.P. revealed that it had opened a new position in Humana and bought 400,000 shares worth $149 million. This means they effectively own approximately 0.1% of the company. Humana makes up 8.5% of the fund's Health Care sector allocation and has decreased its share price by 28.2% in the past year.

The investment fund also strengthened its position in Baxter International by buying 500,000 additional shares. This makes their stake in Baxter International total 5,500,000 shares worth $184 million. Baxter International dropped 19.4% in the past year.

On the other hand, there are companies that Camber Capital Management L.P. is getting rid of from its portfolio. Camber Capital Management L.P. closed its position in Tenet Healthcare on 14th August 2024. It sold the previously owned 1,900,000 shares for $200 million. Stephen Dubois also disclosed a decreased stake in Universal Hlth Svcs Inc by 0.2%. This leaves the value of the investment at $176 million and 950,000 shares.

One of the smallest hedge funds

The two most similar investment funds to Camber Capital Management L.P. are Raine and Braun Stacey Associates Inc. They manage $2.57 billion and $2.58 billion respectively.


Stephen Dubois investment strategy

Camber Capital Management L.P.’s portfolio is diversified across 3 sectors. Currently, their heaviest sector is Health Care — making up 68.3% of the total portfolio value. The fund focuses on investments in the United States as 50.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 32% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $23.7 billion.

The complete list of Camber Capital Management L.P. trades based on 13F SEC filings

These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security Shares Owned Value Allocation
Zimmer Biomet Holdings Inc
No change
1,925,000
$208,920,000 8.14%
Tenet Healthcare Corp.
Closed
1,900,000
$199,709,000
Baxter International Inc.
10.00%
5,500,000
$183,975,000 7.16%
Medtronic Plc
21.62%
2,250,000
$177,098,000 6.90%
Universal Hlth Svcs Inc
24.00%
950,000
$175,684,000 6.84%
Globus Med Inc
No change
2,500,000
$171,225,000 6.67%
Viatris Inc.
7.69%
15,000,000
$159,450,000 6.21%
Humana Inc.
Opened
400,000
$149,460,000 5.82%
Myriad Genetics, Inc.
27.96%
5,500,000
$134,530,000 5.24%
Jazz Pharmaceuticals plc
No change
1,150,000
$122,740,000 4.78%
PTC Therapeutics Inc
12.50%
3,500,000
$107,030,000 4.17%
Brookdale Sr Living Inc
No change
15,500,000
$105,865,000 4.12%
GSK Plc
22.99%
2,675,000
$102,988,000 4.01%
Biomarin Pharmaceutical Inc.
340.00%
1,100,000
$90,563,000 3.53%
Select Med Hldgs Corp
25.00%
2,550,000
$89,403,000 3.48%
CVS Health Corp
Opened
1,500,000
$88,590,000 3.45%
Biogen Inc
Closed
400,000
$86,252,000
Walgreens Boots Alliance Inc
10.26%
7,000,000
$84,665,000 3.30%
Qiagen NV
23.97%
1,500,000
$61,635,000 2.40%
Zimvie Inc
No change
3,250,000
$59,313,000 2.31%
Denali Therapeutics Inc
33.33%
2,000,000
$46,440,000 1.81%
Perrigo Co Plc
No change
1,520,000
$39,034,000 1.52%
Collegium Pharmaceutical Inc
Closed
852,900
$33,110,000
Herbalife Ltd
No change
3,000,000
$31,170,000 1.21%
Argenx Se
Opened
72,000
$30,963,000 1.21%
Sarepta Therapeutics Inc
74.36%
150,000
$23,700,000 0.92%
Peloton Interactive Inc
Closed
4,500,000
$19,283,000
Bicycle Therapeutics plc
103.33%
915,000
$18,520,000 0.72%
Orasure Technologies Inc.
No change
4,250,000
$18,105,000 0.71%
Inogen Inc
No change
2,000,000
$16,260,000 0.63%
Moonlake Immunotherapeutics
Opened
355,000
$15,609,000 0.61%
AnaptysBio Inc
Opened
500,000
$12,530,000 0.49%
Replimune Group Inc
50.91%
1,350,000
$12,150,000 0.47%
Evolent Health Inc
Opened
625,000
$11,950,000 0.47%
Puma Biotechnology Inc
Closed
1,650,000
$8,745,000
Theravance Biopharma Inc
No change
1,000,000
$8,480,000 0.33%
The Beauty Health Company
No change
3,500,000
$6,720,000 0.26%
Curevac N V
68.57%
550,000
$1,870,000 0.07%
Genmab A/s
No change
50,000
$1,257,000 0.05%
No transactions found
Showing first 500 out of 39 holdings